Trial-based economic evaluation of mindfulness-based cognitive therapy compared to treatment as usual for bipolar disorder.
International journal of methods in psychiatric research September 12, 2023 Ben Wijnen, Maud Jansen, Annelieke Van Velthoven et al. 2 citations
Adding mindfulness-based cognitive therapy (MBCT) to treatment as usual (TAU) for adults with bipolar disorder is likely cost-effective compared to TAU alone. Over 15 months, total societal costs were €615 lower for the MBCT-plus-TAU group, and healthcare costs differed significantly between groups. A small gain in quality-adjusted life years (QALYs) combined with lower costs (€836 after adjustment) made MBCT-plus-TAU the dominant strategy. The probability that the combination was cost-effective was 65%. Sensitivity analyses confirmed the robustness of these results. The difference in clinical effect was small or negligible, but the intervention still reduced overall costs.